- AU$1.85bn
- AU$1.40bn
- AU$39.68m
Brief: Pyc Therapeutics Says Has Increased Its Shareholding In Vision Pharma
Brief: Pyc Therapeutics Says FY Loss Attributable A$13.9 Million
Australia Stock Exchange release from PYC THERAPEUTICS : Completes FDA Pre-IND engagement - RP11 program
Australia Stock Exchange release from PYC THERAPEUTICS : Q1 Investor Call Presentation
Australia Stock Exchange release from PYC THERAPEUTICS : Quarterly Investor Call March 2022
Australia Stock Exchange release from PYC THERAPEUTICS : Notification regarding unquoted securities - PYC
Australia Stock Exchange release from PYC THERAPEUTICS : Half Yearly Report and Accounts
Australia Stock Exchange release from PYC THERAPEUTICS : PRE_NR Ends: 19:46:09
Brief: Pyc Therapeutics Increases Shareholding In Vision Pharma
Australia Stock Exchange release from PYC THERAPEUTICS : PRE_NR Ends: 09:28:17
Australia Stock Exchange release from PYC THERAPEUTICS : PYC Increases Shareholding in Vision Pharma
Australia Stock Exchange release from PYC THERAPEUTICS : Becoming a substantial holder
Australia Stock Exchange release from PYC THERAPEUTICS : Quarterly Activities and Appendix 4C Cash Flow Report
Australia Stock Exchange release from PYC THERAPEUTICS : PRE_NR Ends: 10:05:10
Australia Stock Exchange release from PYC THERAPEUTICS : Notification of cessation of securities - PYC
Australia Stock Exchange release from PYC THERAPEUTICS : Change in substantial holding
Australia Stock Exchange release from PYC THERAPEUTICS : Change of Registry Address
Australia Stock Exchange release from PYC THERAPEUTICS : Notification of cessation of securities - PYC
Australia Stock Exchange release from PYC THERAPEUTICS : Appendix C US Sub Plan